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This study evaluated the influence of intestinal conditions on lipolysis and polyphenols release and 10 
bioaccessibility in dark, milk and white chocolates. Chocolates were in vitro digested under different intestinal 11 
conditions of pH (6 and 7), bile concentration (1 and 10 mM) and pancreatic concentrations (1,000 - 3,000 LU 12 
/ g Fat). The lipolysis varied from 300 to 500 mg FFA / g fat in dark chocolate and ranged between 600-1000 13 
mg FFA / g fat in both, milk and white. Polyphenols release in dark chocolate (up to 12 mg GA/ g), seems to 14 
be related to the absence of dairy compounds. Finally, no effect of intestinal pH or biliary concentration was 15 
found on the lipolysis in digested dark and milk chocolates. The oral pancreatic supplementation, however, 16 
was crucial to lipolysis and polyphenols release in all chocolates, even if no differences were found on these 17 
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1. Introduction 23 
Chocolate is a fat continuous matrix within which there are particles of cocoa powder, sugar, and in the case 24 
of milk chocolate, milk powder. Besides the high fat content of chocolate, generally exceeding 30 g of fat per 25 
100 g of food (United States Department of Agriculture, 2018), it has lately gained attention mainly due to its 26 
main component, cocoa. In fact, cocoa is well known for its lipid and antioxidant properties. Cocoa butter, has 27 
a lipid profile characterized mainly by oleic, stearic (≈34% w/w) and palmitic (≈27% w/w) acids, followed by 28 
minor fractions of linoleic, arachidic, palmitoleic, margaric, α-linoleic and myristic acids. In addition, cocoa is a 29 
polyphenols-rich product, being one of the largest known food sources of flavan-3-oles, mainly epicatechin, 30 
catechin and notably procyanidins (Beckett, 2008; Jalil & Ismail, 2008).  31 
In the last years, many studies have reported a relation between the consumption of cocoa derivatives, 32 
especially dark chocolate, with beneficial health effects on cardiovascular and degenerative diseases, related 33 
to the antioxidant activity of procyanidins (Almoosawi, Tsang, Ostertag, Fyfe, & Al-Dujaili, 2012; Cooper, 34 
Donovan, Waterhouse, & Williamson, 2008; Jalil & Ismail, 2008; Keen, Holt, Oteiza, Fraga, & Schmitz, 2005; 35 
Ortega, Reguant, Romero, Macià, & Motilva, 2009). Most of these studies extensively reported not only the in 36 
vitro health benefits of cocoa consumption but also its effects in vivo (Jalil & Ismail, 2008; Kurosawa et al., 37 
2005; Matsui et al., 2005; Ramiro et al., 2005; Vinson et al., 2006). However, while most polyphenols showed 38 
antioxidant action in vitro, they did not necessarily exert antioxidant potential in vivo (Cooper et al., 2008; Jalil 39 
& Ismail, 2008). Related to the health protective effects of cocoa polyphenols, it is important to point out the 40 
modifications that undergo the processing of cocoa such as seed fermentation, roasting, nib-grinding, 41 
alkalizing, tempering, molding or enrobing, cooling, and packing (Beckett, 2008; Ortega et al., 2009; Wollgast 42 
& Anklam, 2000) might modify the chemical features of polyphenols compounds and therefore, their effects on 43 
health.  Besides, it is also important to consider the interaction that polyphenols might exert with other 44 
components within the food matrix, such as macromolecules, since these can have significant effects on their 45 
bioaccessibility and bioavailability (Jakobek, 2015). For instance, the interaction between lipids and 46 
polyphenols has been reported in literature. In a previous study of in vitro digestibility of cocoa polyphenols in 47 
a matrix containing fat, Ortega et al. (2009) suggested that the fat content in the cocoa liquor could have a 48 
protective effect on cocoa polyphenols because it enhances the micellarization and stability of polyphenols 49 
during digestion. Additionally, the access of free radicals to lipid molecules can be hindered by the presence 50 
of polyphenols in lipid molecules, reducing the harmful caused by lipid oxidation products (Jakobek, 2015). On 51 
the other hand, it has also been found that polyphenols affected the emulsification taking place during the 52 
gastrointestinal process by increasing the droplet size and decreasing specific surface area, causing in addition 53 
a decrease in the activity of the gastric and/or pancreatic lipases (Shishikura, Khokhar, & Murray, 2006; 54 
Sugiyama et al., 2007; Uchiyama, Taniguchi, Saka, Yoshida, & Yajima, 2011).  55 
Food components, such as polyphenols or lipids, will need to be released from their food matrix in order to be 56 
bioavailable, so they can become then absorbable (bioaccessible), meaning they can be absorbed by intestinal 57 
cells and be metabolized (Asensio-Grau, Peinado, Heredia, & Andrés, 2018; Faulks & Southon, 2005; 58 
Nimalaratne, Savard, Gauthier, Schieber, & Wu, 2015). Nutrients bioaccessibility will depend on different 59 
factors related to the food itself such as food composition, its matrix, type of nutrients, and/or processing 60 
conditions (Granado-Lorencio et al., 2007; Nimalaratne et al., 2015; Pineda-Vadillo et al., 2017; Ryan, 61 
O’Connell, O’Sullivan, Aherne, & O’Brien, 2008). In addition, individual factors such as gastrointestinal 62 
conditions (pH, secretion and composition of the digestive fluids, transit time…) might affect the release of 63 
food bioactive compounds (Ryan et al., 2008; Whitcomb et al., 2010). All this leads to the importance of 64 
analysing to which extent not only food matrix, but other factors, can modify the stability and the bioaccessibility 65 
of bioactive compounds, in order to better understand the biological activity of food constituents (Rodríguez-66 
Roque et al., 2015).  67 
In fact, individual gastrointestinal conditions might be different among different individuals depending on their 68 
age, gender, diet, etc. (Shani-Levi et al., 2017). These differences will become even more relevant under 69 
specific digestive disorders. For instance, special attention has been addressed to rich-fat foods for dietary 70 
recommendations aimed at subjects with specific requirements of fat intake. This is the case of individuals 71 
suffering of exocrine pancreatic insufficiency (EPI). EPI is a physiological disorder characterized by a decrease 72 
of secretions of Cl-, water and HCO-3, with the consequent decrease of pancreatic and biliary secretions, 73 
causing dilation and obstruction of the pancreatic and bile ducts (Li & Somerset, 2014). Due to alterations at 74 
pancreatic level, a deficiency in the production of digestive enzymes at the duodenum might occur, leading 75 
this, to malnutrition and some associated problems. Currently, the treatment of EPI is carried out by enzymatic 76 
substitution therapy (EST), which consists on oral administration of porcine pancreatin formulated as gastro-77 
resistant microcapsules. Actual guidelines of the supplement advise an enzyme amount of 2,000 Lipase Units 78 
LU/ g fat intake, based on the overall fat content of the meals or on patients body weight (Turck et al., 2016). 79 
However, these recommendations seem, nowadays, insufficient for the efficiency of the treatment since host-80 
factors such as intestinal pH, bile concentration as well as food intrinsic ones (composition, structure and lipid 81 
organization in the food-matrix among others) might have a significant impact on the efficiency of the 82 
supplement, and therefore on macronutrients digestion  (Rovner, Schall, Mondick, Zhuang, & Mascarenhas, 83 
2013). 84 
In this way in vitro digestion models are considered useful tools that can be used to study the digestive 85 
properties of different food forms, helping to understand the mechanisms behind the differences observed in 86 
vivo. To the authors knowledge, there are already some studies focusing on lipids absorption and polyphenols 87 
bioaccessibility of cocoa based products (Jalil & Ismail, 2008; Kurosawa et al., 2005; Matsui et al., 2005; 88 
Ortega et al., 2009; Ramiro et al., 2005; Vinson et al., 2006), however, in all of them, gastrointestinal conditions 89 
were simulated according to a standard healthy adult. Therefore, the aim of the present study was to evaluate 90 
the differences between dark, milk and white chocolate in terms of lipids digestibility and bioaccessibility of 91 
total polyphenols under different intestinal conditions (pH, concentration of bile and pancreatic enzymes). 92 
Besides, the enzymatic supplementation leading to the highest in vitro lipolysis extent under unfavourable 93 
intestinal conditions will be obtained for each chocolate. 94 
 95 
2. Materials and Methods 96 
2.1. Raw Material  97 
Three types of chocolates, available in packets of 100 g each, were purchased from a local supermarket (Dark 98 
chocolate (D), Milk chocolate (M), White chocolate (W)), all of them form the same brand. Table 1 details the 99 
nutritional and compositional information available in the label.  100 
2.2 Chemicals 101 
α-amylase from human saliva (1000-3000 U/ mg protein) and pepsin from porcine gastric mucosa (≥ 2,500 U/ 102 
g protein), were obtained from Sigma-Aldrich. Pancreatin from swine pancreas (Kreon® 10,000 lipase units 103 
(LU), Abbot), was kindly donated by “Hospital Universitari Politècnic La Fe” (Valencia, Spain). Each capsule 104 
contains 150 mg of porcine pancreatic enzyme equivalent to 10,000 lipase U., 8,000 amylase U. and 600 105 
protease U.  106 
The following chemicals were needed for preparation of the simulated digestive fluids: bovine bile extract, KCl, 107 
KH2PO4, NaHCO3, NaCl, MgCl2 (H2O)6, (NH4)2CO3 and CaCl2 all of them from Sigma-Aldrich Chemical 108 
Company (St Louis, MO, USA). NaOH (1 N) and HCl (1 N), were acquired from AppliChem Panreac. For the 109 
analytical determinations, all solvents were analytical grade; Triton-X 100%, ethanol 96% (Labkem), enzymatic 110 
kits for the analysis of free fatty acids (Roche Diagnostics, Indianapolis, IN, USA). The analytical standards 111 
oleic acid and for the content of total polyphenols, methanol, Folin-Ciocalteu reagent, Na2CO3, gallic acid (GA) 112 
were all from Sigma-Aldrich).  113 
2.3 In vitro simulation of gastrointestinal digestion 114 
2.3.1 In vitro Digestion process 115 
The digestion procedure used was based on the standardized static in vitro digestion method for food 116 
published by Minekus et al. (2014) with some modifications in order to simulate EPI conditions as detailed in 117 
previous studies (Asensio-Grau et al., 2018; Peinado, Larrea, Heredia, & Andrés, 2018). The digestion fluids 118 
were prepared fresh from stock solutions, salivary (SSS), gastric (SGS) and intestinal (SIS) according to 119 
Minekus et al. (2014). Table 2 summarizes composition and amounts of the fluids used in each of the stages 120 
of the digestion process. The enzymatic activity was tested before each experiment following the protocol 121 
proposed by Carrière et al., (2000). Each experimental condition was performed in triplicate. The in vitro 122 
digestion was performed as follows:  123 
Oral stage: chocolates samples were mechanically broken down with a mortar, and the amount of sample to 124 
be digested was weighted in order to have 0.35 g fat in each tube (50 mL falcon tubes). Simulated salivary 125 
fluid (5 mL) (SSF; pH 8) at 37 ºC, was added to the falcon tubes containing chocolate samples in a ratio 1:1 126 
(v/w), and then they were properly homogenized and incubated for 3 minutes at 37 ºC in an incubator chamber 127 
Selecta (JP Selecta SA, Barcelona). Human α-amylase was added as a part of SSF to reach a concentration 128 
in the saliva mixture of 75 U/ mL. 129 
Gastric stage: after the oral stage, simulated gastric fluid (SGF; pH 3) was added to each tube containing the 130 
oral bolus (1:1 v/w). Pepsin was added into the SGF to reach a concentration in the gastric mixture of 2,000 131 
U/mL. The pH of the mixtures was adjusted with HCl (1N) to pH 3 ± 0.1 and samples were flipped from top to 132 
bottom at 55 rpm for 120 minutes at 37 ºC using an Intell-Mixer RM-2 (Elmi Ltd, Riga, LV-1006, Latvia) and 133 
incubated in a chamber Selecta (JP Selecta SA, Barcelona). These conditions provide mechanical energy to 134 
cause the disintegration of the food matrix during gastric digestion, in a similar way as it happens 135 
physiologically.  136 
Intestinal stage: following the gastric stage, simulated intestinal fluid (SIF; pH 7) containing bile salts (1 or 10 137 
mM) and pancreatin (0; 1,000; 2,000; 3,000 LU/g of fat) was added in a proportion 1:1 (v/w) to each tube 138 
containing the gastric chime. The pH of the mixtures was adjusted with NaOH (1N) to pH 6.0 ± 0.1 or 7.0 ± 139 
0.1, depending on the experimental design. Samples were then flipped from top to bottom at 55 rpm for another 140 
120 minutes at 37 ºC. pH was monitored during the digestion process and readjusted if necessary as pH below 141 
5.7 might inactivate lipase activity (González-Bacerio, Rodríguez Hernández, & del Monte Martínez, 2010; 142 
Prazeres, Garcia, & Cabral, 1994). 143 
2.3.2. Experimental design 144 
The experimental design for each type of chocolate consisted of two sets of experiments. In the first set, the 145 
amount of pancreatic enzymes was fixed at 2,000 LU/g of lipid, and the study variables consisted on different 146 
combinations of intestinal pH/bile concentration (pH6/1mM, pH6/10mM, pH7/1mM and pH7/10mM) in order to 147 
analyse the impact of different intestinal conditions on the lipolysis and bioaccessibility of total polyphenols. In 148 
this scenario, pH 7 and 10 mM of bile salts would correspond to the standard intestinal conditions of a healthy 149 
adult (Minekus et al., 2014); while pH 6 and 1 mM would correspond to the most disadvantageous scenario in 150 
EPI individuals (Gelfond, Ma, Semler, & Borowitz, 2013). In the second experimental set, intestinal conditions 151 
were fixed at pH 6 and bile salts concentration 1 mM, and different pancreatic enzymes amounts (0; 1,000; 152 
2,000 and 3,000 LU/g of fat) were tested in order to assess the influence of enzyme concentration. All the 153 
experiments were designed to analyse the impact of different intestinal scenarios on matrix degradation index, 154 
lipolysis extent, and total polyphenols release.   155 
2.4. Analytical determinations 156 
Immediately after digestion, samples were placed in ice for 10 minutes in order to stop the enzymatic reactions 157 
before performing the analytical determinations. After that, tubes were centrifuged (4,000 x g-force during 20 158 
minutes, 10 ºC) to separate the solid fraction from the liquid phase. After centrifugation, the total content of 159 
each tube was filtered through a metallic sieve (1.6 mm x 1.6 mm mesh) to separate out solid food particles. 160 
These solid particles were rinsed twice with 5 mL of appropriate juice to remove any digested material. Blotting 161 
paper was placed around the metallic sieve for 10 min to drain residual digestion juice. The undigested 162 
chocolate particles (solid particles) were then transferred to an aluminum dish (previously weighed). The 163 
drained liquid, called from now on “liquid phase”, was collected and 0.1 mL was used for free fatty acids 164 
analyses; the remaining liquid phase was freeze-dried (-40°C and 1.25 mbar, Telstar, Terrassa, Spain) and 165 
stored for polyphenols determination.  166 
        2.4.1 Matrix Degradation Index (MDI %) 167 
Matrix degradation Index was determined in all samples after in the vitro digestion process. This parameter 168 
represents the proportion of solids dispersed in the digestion fluids after duodenal digestion. The aluminum 169 
dish with the undigested particles was placed in a forced air oven at 60º C for 48 h until constant weight. The 170 
matrix degradation index (MDI) corresponding to the proportion of chocolate particles passing the metallic 171 
sieve and was calculated according to Lamothe, Corbeil, Turgeon, & Britten (2012). 172 
2.4.2 Lipolysis extent (mg FFA/ g fat) 173 
0.1 mL of the liquid phase of each sample was diluted in 10 mL of an aqueous solution (5.6 % Triton X-100 174 
and 6 % ethanol in water) to solubilize the free fatty acids and inactivate any remaining activity of pancreatic 175 
enzyme. Fatty acids release during digestion was estimated using a spectrophotometric assay kit (Roche 176 
Diagnostics, Indianapolis, IN, USA) in a spectrophotometer (UV/vis, Beckman Coulter) at 564 nm (Lamothe et 177 
al., 2012; Asensio- Grau et al., 2018; Peinado et al., 2018). Oleic acid standard was used for quantitative 178 
determination of FFA (Free Fatty acids), since it is the major fatty acid in chocolate fat (Beckett & Stephen, 179 
2008). Digested fat was estimated assuming the maximum release of 2 mol of fatty acids per 1 mol of 180 
triglycerides (Hunter, 2001), and results were expressed as mg of FFA, considering the average of molecular 181 
weight of oleic acid 282.47 g mol-1. 182 
2.4.3 Total Polyphenols content 183 
Total polyphenols in the digested fluids were determined by the modified protocol of the Folin–Ciocalteu assay 184 
(Singleton, Orthofer, & Lamuela-Raventós, 1998). Freeze dried powder (digested chocolate liquid phase (50 185 
mg), and solid undigested phase (50 mg)) was extracted using methanol (1 mL, 30:70 methanol-water solution 186 
(v: v)) by means of agitation at 55 rpm, for 120 min at 25 ºC using an Intell-Mixer RM-2 (Elmi Ltd, Riga, LV-187 
1006, Latvia). The mixture was then centrifuged at 14.1 x g-force for 20 minutes (Eppendorf® Minispin®). After 188 
centrifugation, methanolic extracts (125 μL) were added into a 4 mL plastic cuvette with distilled water (0.5 189 
mL) and Folin-Ciocalteu reagent (125 μL). After 5 min, 1.25 mL of Na2CO3 solution (7% [w/v]) and distilled 190 
water (1 mL) were added and measurements recorded after 30 min, at a wavelength of 660 nm. Gallic acid 191 
(0–700 μmol of gallic acid / L) was used as standard. Results were expressed as mg of gallic acid (GA) 192 
equivalent per gram of food.  193 
2.5 Statistical analyses 194 
Analysis of variance (simple and multivariate ANOVA) followed by Fisher LSD post-hoc tests were performed 195 
to find out the statistical significance of the type of chocolate and the intestinal variables (pH, bile salts 196 
concentration (mM) and pancreatin amount (UL/ g fat)) on MDI (%), lipolysis extent (%), and polyphenols 197 
release (mg GA/ g) by means of Statgraphics Centurion. Differences were considered statistically significant 198 
when p<0.05. 199 
 200 
3. Results and discussion 201 
3.1. Effect of intestinal conditions on matrix degradation Index (%) of the digested chocolates 202 
The matrix degradation index (MDI) corresponds to the percentage of digested particles and it provides global 203 
information about the extent of different processes (solubilisation, mechanical disruption, chemical and 204 
enzymatic reactions) undergone by the food matrix during oral, gastric and intestinal stages. During digestion, 205 
food absorbs a significant amount of water, and together with the action of digestive enzymes it promotes the 206 
softening of the matrix and the reduction of cohesive forces; depending on the food matrix composition and 207 
structure it will result in different degradation extent (Kong & Singh, 2009). Additionally, in fat continuous 208 
products as chocolate, softening and matrix disruption is mainly due to melting of fat as oral temperature. Table 209 
3 shows the results of MDI of the different chocolate types after the in vitro digestion process at different 210 
intestinal pH and bile concentrations, as well as for 2,000 LU / g fat and different pancreatin amounts. MDI 211 
ranged from 50 to 75 % (average value) in dark chocolate, while it reached 87 to 94 % (average value) in the 212 
other two types of chocolates (milk and white chocolate). The statistical analyses revealed that neither the 213 
intestinal pH, the bile concentration nor the amount of pancreatin had a significant effect on MDI. The significant 214 
differences in this parameter were found to depend on the type of chocolate (p< 0.001), being the dark 215 
chocolate the one showing the lowest values of MDI.  216 
It is important to consider how the different ingredients in chocolates (fat, lecithin and crystalline lactose) might 217 
affect their structure and therefore, their matrix degradation when they undergo digestion. Chocolate 218 
microstructure is the result of many factors including particle size, amount and distribution of fat, type and 219 
amount of emulsifier and solid particles (Afoakwa, Paterson, Fowler, & Vieira, 2009). Among the main 220 
components of chocolate, the most soluble is sugar, which will explain the major degradation of chocolates 221 
containing high content of this ingredient. In addition, the amount of fat will affect particle interactions, related 222 
to their distances and distribution within the food matrix (Glicerina, Balestra, Dalla Rosa, & Romani, 2016). In 223 
their study Glicerina et al., (2016), compared the microstructural and rheological properties of dark, milk and 224 
white chocolate, revealing that dark chocolate showed a more aggregated structure, with the lowest minimum 225 
distance between particles and less open spaces (filled with fats) than milk chocolate samples. These 226 
microstructural properties would explain the lower MDI obtained in digested dark samples (Table 3) compared 227 
to white and milk samples. The MDI values of white chocolate were the highest, although very similar to the 228 
values obtained for milk chocolate samples, probably due to the similar amount of fat in both samples (Table 229 
1). However, the more aggregated microstructure due to the presence of cocoa particles between the sugar 230 
ones in milk chocolate would explain the lower values of MDI compared to the white chocolate.   231 
3.2. Effect of intestinal conditions on total polyphenols release from the digested chocolates and on 232 
their final bioaccessibility  233 
Figure 1 shows the polyphenols content (mg equivalent of gallic acid / g of chocolate) of dark, milk and white 234 
chocolate for both, solid undigested chocolate as well as digestion fluids, after oral, gastric and intestinal 235 
digestion. The effect of intestinal pH (6 or 7) and bile concentration (1 and 10 mM) on these antioxidants is 236 
also gathered in this figure. As it can be observed, the initial quantity of polyphenols seemed to be directly 237 
related to the cocoa content in the product.  Of note, dark chocolate presented the highest polyphenols content, 238 
five-fold superior to the content found in milk chocolate and seven-fold than in white chocolate. As it can be 239 
observed, the oral stage characterised by simulated mastication and primary hydrolysis of glucids by α-240 
amilase, resulted in a low release of polyphenols mainly due to the short duration of this stage. Therefore, 241 
most polyphenols remain in the solid phase, i.e. in the food matrix, after simulated mastication. The acidic pH, 242 
together with the enzymatic proteolysis carried out by pepsin on chocolate-protein (6, 7 and 10.4% in white, 243 
milk and dark chocolate, respectively) and the mechanical disruption acting during 120 min, were the main 244 
responsible of the increase of total polyphenols content during this gastric digestion.  245 
It is important to point out that the polyphenols method quantifies only soluble polyphenols. According to these 246 
results, it seems that polyphenols take part in complex molecules before digestion, being released from these 247 
structures under both, gastric and intestinal conditions. In food, polyphenols are found mainly as esters, 248 
glycosides and polymers usually not absorbable in those forms, and therefore they need to be hydrolysed by 249 
digestive enzymes or intestinal microflora. Due to the low pH in the stomach, the flavonoid oligomers are 250 
transformed into smaller units. The flavon-3-ols pass intact to the duodenum in the form of aglycones. In the 251 
small intestine, deglycosylation, glucuronidation, methylation, sulphonation and hydroxylation of flavonoids 252 
occurs. Under alkaline pH conditions in the small intestine, the absorption of free phenolic acids occurs. 253 
Undigested polyphenols then pass into the large intestine, where colonic microflora degraded them into 254 
phenolic acids (Tarko, Duda-Chodak, & Zajac, 2013). Different factors such as mechanical destruction, nature 255 
of the food matrix, residence time under different gastrointestinal conditions and the enzymatic action 256 
contribute positively to the physic-chemical release of the phenolic compounds, resulting in an augmentation 257 
of the total free polyphenols content. Moreover, most polyphenols are present in the liquid phase compared to 258 
those present in the solid phase after gastric and intestinal stages, and therefore they would be more 259 
bioaccessible, and hence available to be absorbed. Of note, the solubilisation and release of polyphenols in 260 
digested white chocolate reached its maximum value during the intestinal stage, being comparable to milk 261 
chocolate, despite its low initial content of polyphenols in the undigested product.  Even if polyphenols content 262 
was higher at pH 7 and 1 mM than under the other studied conditions, a slight increase in polyphenols released 263 
within the liquid phase was observed for the highest bile concentration (10 mM) at pH 6.  A clear effect was 264 
not found, however, depending on bile concentration for intestinal pH 7. This could be explained, due to the 265 
fact that the optimum pH for pancreatic enzymes ranges from 7 to 8 (González-Bacerio et al., 2010; Prazeres 266 
et al., 1994). In fact, in a previous study on milk lipolysis, Peinado et al., (2018) reported that the relevance of 267 
bile salts concentration was higher at low intestinal pHs than at higher  (7 and 8). In this scenario, bile salts 268 
motivate lipolysis-products transportation (mainly free fatty acid and monoglycerides) from the lipid surface to 269 
the intestinal fluid and their further micellation, facilitating thus, solubilisation of digestion products such 270 
antioxidants (Maldonado-Valderrama, Wilde, MacIerzanka, & MacKie, 2011). Regarding the type of chocolate, 271 
white and milk chocolate are mainly made from cocoa butter, an extract from cocoa liquor, containing phenolic 272 
compounds in less proportion. In contrast, dark chocolate is mainly made with cocoa liquor what is reflected 273 
in the results regarding to the polyphenols content and final bioaccessibility. Figure 2 details the release and 274 
solubilisation of phenolic compounds (mg equivalent GA / g of chocolate), depending on the amount of 275 
pancreatin (0-3,000 LU/ g fat), at constant conditions of pH (6) and biliary concentration (1 mM). A positive 276 
effect of the presence of pancreatin on the soluble content of polyphenols was observed. According to these 277 
results, the oral supplementation with encapsulated pancreatin seems to be crucial for polyphenols release 278 
under EPI conditions. The amount of pancreatin, however, was only relevant for the polyphenols release with 279 
digested dark chocolate. The absence of dairy compounds in dark chocolate might be favourable, given that 280 
a negative effect of caseins on polyphenols release has been reported (Keogh, McInerney, & Clifton, 2007). 281 
Their antioxidant activity seems to be also compromised in presence of α-casein (Bourassa, Côté, 282 
Hutchandani, Samson, & Tajmir-Riahi, 2013) and milk β-lactoglobulin by the formation of weak bonds between 283 
these proteins and polyphenols (Kanakis et al., 2011), which is the case for milk and white chocolate. Previous 284 
studies have demonstrated the reduction of the antioxidant potential by the union of phenolic compounds with 285 
milk proteins, reducing their accessibility (Kilmartin & Hsu, 2003; O’Connell, Fox, Tan-Kintia, & Fox, 1998). 286 
Some previous studies have highlighted a positive correlation between the percentage of cocoa solids 287 
identified in the labelling and the concentration of polyphenols (Vinson & Motisi, 2015). This information could 288 
allow consumers identifying those chocolates with greater content of pure cocoa which directly affects the 289 
bioavailability of its antioxidants. The above mentioned relation has been highlighted in previous studies 290 
(Ortega et al., 2009) in which it is emphasized that a higher content of fat in the digested fluids, favours the 291 
formation of emulsified fat drops and with it, the incorporation of cocoa phenols in the lipid phase, protecting 292 
them during the duodenal stage. It is also important to emphasize that the consumption of polyphenols in 293 
pieces of dark chocolate produces a post-prandial anti-oxidant effect in vivo human despite the presence of 294 
fats and sugars in the product (Keen et al., 2005; Ortega et al., 2009). 295 
3.3. Lipolysis extent affected by chocolate type and intestinal conditions  296 
During digestion chocolate is mixed with digestive fluids and so the hydration of the matrix occurs, leading this 297 
to the solubilisation of some components such as sugars, together with the melting and emulsification of fat. 298 
Additionally, the digestive enzymes activity is responsible of macronutrients hydrolysis, and due to the high fat 299 
content of chocolates, lipolysis extent after the in vitro digestion process was analysed. Since fat digestion 300 
mainly takes place at the duodenum, and because it can be affected by pH, bile concentration and pancreatic 301 
enzyme activity in the case of exocrine pancreatic insufficiency, different conditions were analysed. Figure 3A 302 
shows the concentration of FFA/ g of fat in the digested samples at different intestinal conditions. These results 303 
reveal that the influence of intestinal pH and bile concentration depends on the type of chocolate; while milk 304 
chocolate lipolysis does not depend on pH or bile concentration, a significant influence of both factors was 305 
found for both, dark and white chocolate lipolysis, being more significant in the case of white chocolate. These 306 
results are related with the above-mentioned factors affecting MDI and polyphenols release, which are also 307 
involved in lipolysis extent during digestion. Food lipids have to be accessible to the digestive enzymes and 308 
especially to pancreatic lipase, so it would be expected that those samples with lower MDI would be the ones 309 
presenting lower progress of lipolysis. This is the case of dark chocolate samples, which reached the lowest 310 
values of FFA/g of fat after digestion independently of the intestinal conditions applied during the in vitro 311 
digestion. The more aggregated structure of this type of chocolate makes difficult, not only the matrix 312 
disintegration, but also the fat digestion. On the contrary, for milk chocolate, which has a less aggregated 313 
structure with more open spaces (filled with fats) than dark chocolate, higher values of lipolysis were obtained. 314 
Additionally, the milk proteins that characterize milk chocolate are mainly 80 % of caseins and 20 % of whey 315 
proteins. The casein fraction acts as surfactant reducing the viscosity of the chocolate (Afoakwa, Paterson, & 316 
Fowler, 2007) and this decrease in viscosity improves lipid digestibility (Guo, Ye, Bellissimo, Singh, & 317 
Rousseau, 2017); and thus the effect of biliary salts and intestinal pH is not as important as in the case of the 318 
other two types of chocolate. 319 
In order to analyse the influence of pancreatic enzyme concentration on lipolysis extent, chocolate samples 320 
were in vitro digested in presence of different LU per gram of fat. The most critical intestinal conditions were 321 
applied, mimicking the exocrine pancreatic insufficiency (pH6 and bile 1mM) (Figure 3B). No significant 322 
differences were found between the enzyme amount used above and below the recommendation (2,000 LU/g 323 
fat), but it draws attention that white chocolate reached lower values of lipolysis extent than the milk one, in 324 
spite of being the samples with the highest MDI. These results can be explained comparing the formulation of 325 
both types of chocolate, and especially those ingredients acting as emulsifiers since they usually play a key 326 
role during lipids digestion. The effect of interfacial molecules on lipolysis has been well described in the 327 
literature. Borgström, & Erlanson (1973) and Borgström & Erlanson (1978) found that high surfactant 328 
concentration inhibited lipolysis even in the presence of colipase, and postulated that the bile salts desorbed 329 
the surfactants allowing lipase adsorption in the presence of colipase. The low bile concentration used in this 330 
work (to mimic abnormal conditions in some chronic diseases such in Cystic Fibrosis) together with the 331 
presence of certain emulsifiers would explain the obtained results of FFA. E476 is a synthetic vegetable fat 332 
obtained by a combination of polyglycerol and castor oil, which has been reported in the literature to delay 333 
lipolysis (Shima, Tanaka, Kimura, Adachi, & Matsuno, 2004). It is worth noting, that polyglycerol 334 
polyrincinoleate (E476) is found among the emulsifiers included in white chocolate formula, while it is not 335 
included in dark and milk chocolate. In the case of dark chocolate, it is also important to highlight the effect of 336 
antioxidants on lipid digestibility. The polyphenols affect the emulsion that occurs during the digestive transit, 337 
increasing the particle size and decreasing the specific surface area, causing a decrease in the activity of the 338 
lipase (Sugiyama et al., 2007; Uchiyama et al., 2011). Thus, small differences in the formulation of chocolates, 339 
especially those with emulsification properties, can have a significant impact on fat digestion, especially under 340 
abnormal conditions of bile secretion. 341 
 342 
4. Conclusions 343 
As the results have shown, we can conclude that it is the type of chocolate the main factor affecting matrix 344 
degradation index during digestion. The different ingredients and their proportion that conform the food matrix, 345 
like fat, emulsifiers, and crystalline lactose, have a significant impact on the structure and consequently their 346 
matrix degradation during digestion.  347 
Under EPI conditions it is important the supplementation of pancreatin for polyphenols release, especially in 348 
the case of dark chocolate, which is the one with the highest polyphenols content. A slight increase of 349 
polyphenols on the liquid phase for the different chocolates was found by increasing the bile concentration at 350 
low pH (6); while no influence of biliary salts was found at higher intestinal pH (7). Additionally, a negative 351 
effect in the antioxidant activity due to the dairy compounds in milk and white chocolate was observed. 352 
Regarding the influence of different intestinal conditions on lipolysis extent, pH and bile concentration do not 353 
determine the extent of lipolysis in milk chocolate, nevertheless, an influence of both factors was found in both, 354 
dark and white chocolate lipolysis. No significant differences were observed between the different amounts of 355 
pancreatin used below or above the recommended one (2,000 LU / g fat). If we speak about lipolysis, it is 356 
important to consider those factors that, due to the nature of the matrix, will affect the results. This is how the 357 
presence of emulsifiers in the case of white chocolate, or the presence of antioxidants in dark chocolate 358 
determined a decrease in lipolysis.  359 
To sum up, the results obtained in the present study highlight the influence that not only food related factors 360 
such food composition, food matrix, processing conditions etc., but also individual physiological parameters 361 
(intestinal pH and bile concentration) might have on nutrients release and bioaccessibility. However, in vivo 362 
studies are advisable to be conducted in order to complement these findings and assist food industry in 363 
developing tailor-made foodstuffs and to help health professional and dieticians to adapt the existing nutritional 364 
guidelines addressed to specific target populations in which intestinal conditions could be altered.  365 
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 509 
  510 
Figure Captions: 511 
Figure 1. Polyphenols content (mg Gallic Acid eq/ gram of chocolate) along the in vitro digestion of different 512 
type of chocolates (dark, milk and white) at intestinal conditions of pH 6 or 7, bile concentration of 1 or 10 mM 513 
and at a fixed pancreatic enzyme amount of 2,000 LU/ g fat. Polyphenols content has been measured in 514 
chocolate before digestion (discontinuous line), and in both, liquid and solid phases, in digested chocolate.  515 
 516 
Letters a-e refer to the homogenous groups obtained by the Fisher LSD post-hoc test after the ANOVA applied 517 
to data to each chocolate type, they provide information about the effect of the different digestion stages on 518 
the release of polyphenols available for absorption (p-value <0.05). 519 
 520 
Figure 2. Polyphenols content (mg Gallic Acid eq/ gram of chocolate) after in vitro digestion of different type 521 
of chocolates (dark, milk and white), digested under fixed intestinal conditions (pH 6 and bile concentration 1 522 
mM) and different pancreatin concentrations (0-3,000 LU/ g fat). (A) Values from liquid phase (B) values from 523 
solid phase. 524 
 525 
Letters a-c refer to the homogeneous groups obtained by the Fisher LSD post-hoc test after the ANOVA 526 
applied to data within each single type of chocolate and they provide information about the release of 527 
polyphenols under different pancreatin concentrations. Letters A-C refer to the homogenous groups obtained 528 
by the Fisher LSD post-hoc test after the ANOVA applied to data between all type of chocolates for each single 529 
pancreatin concentration; thus they provide information related to the effect of the type of chocolate on the 530 
release of polyphenols (p-value <0. 05).   531 
 532 
 533 
Figure 3. A) Lipolysis (mg FFA/g fat) after the in vitro digestion with a fixed pancreatin concentration (2000 534 
LU/ g fat) and different combinations of intestinal pH and bile concentrations (pH 6 or 7, bile salts concentration 535 
1 or 10 mM); B) Lipolysis (mg FFA/g fat) after the in vitro digestion under fixed intestinal conditions (pH 6 and 536 
bile concentration 1 mM) and different pancreatin concentrations (0-3,000 LU/ g fat). 537 
Letters (a-b “lower case”) refer to the homogenous groups obtained by the Fisher LSD post-hoc test after the 538 
ANOVA applied comparing between different lipase concentrations or intestinal conditions within the same 539 
type of chocolate, and letters (A-C "capital letters") refer to the homogenous groups obtained by the Fisher 540 
LSD post-hoc test after the ANOVA applied comparing between different type of chocolates for each 541 
experimental condition (p-value <0.05). 542 
 543 
